Israel-based Paieon Inc. has received the infusion of $3.5 million from Vectop Ltd. and private investors, as reported in today’s Globes. The company is trying to commercialize its proprietary 3D coronary visualization technology, designed for navigation in the cath lab. The CardiOp-B System has already been approved for marketing in Canada.
Here’s a glance at the technology:
The CardiOp-B System is a standalone PC based workstation that connects to the CathLab through a DICOM interface.
The CardiOp-B system performs 3D reconstruction in real-time of coronary arteries from standard angiography images. As a quantitative tool, CardiOp-B performs measurements based on the 3D vessel analysis, thereby overcoming confounding factors that may be present in 2D, such as foreshortening. CardiOp-B provides quantification of stenosis and vessel parameters such as diameter, length, eccentricity, angulation and tortuosity. Complex anatomies, such as bifurcations and tortuous lesions are displayed and analyzed. Accurate 3D visualization and quantitative data assist in determining optimal treatment strategy and selection of interventional devices.
CardiOp-B is the platform for additional products that will optimize percutaneous coronary interventions. Among these is CardiOp-Guidance that will enable accurate positioning of therapeutic devices, such as drug- eluting stents, based on the 3D reconstruction.
The CardiOp-B system is the world’s first commercial 3D imaging system for real-time use in interventional cardiology procedures. With an increasing number of installations worldwide and through continuous clinical studies at distinguished medical and research institutions, Paieon has achieved a leadership position. The CardiOp-B system is becoming recognized as the “Gold Standard” system for 3D Quantitative vascular analysis.
The CardiOp-B is based on optimization of angiographic data with no additional intervention. Real-time data is presented in the form of an intuitive, interactive 3D reconstruction. There is no disruption to the standard diagnostic or interventional procedure. The CardiOp-B clinical benefits include:
Accurate, non-foreshortened lesion length measurement for device sizing 3D appreciation of vessel tortuosity Bifurcation angle measurement Projection independent cross section and diameter stenosis measurement